
Australian ASX200 earnings preview A2M
The A2 Milk Company Limited (A2M) is a dual-listed NZX and ASX 50 public listed company that commercialises intellectual property relating to A1 protein-free milk that is sold under the a2 and a2 Milk brands as well as the milk and related products such as infant formula. Its products are sold in Australia, New Zealand, U.S, China, Korea, and the United Kingdom. It reports its full-year numbers on Thursday, the 26th of August.
Share this:
At the start of the pandemic, A2 Milk was a beneficiary as sales surged on a wave of panic buying. In response, A2 Milk upgraded its full-year earnings guidance in April 2020 by 32%. Shortly afterwards, in June 2020, the share price traded to its all-time high of $20.05c.
Since that point, a drastic reversal of fortune has occurred.
In its half year update in February, A2 Milk downgraded its full-year guidance in response to the fallout from a decline in daigou sales. A2 Milks products were purchased in NZ and Australia and then shipped into China to sell to customers there. The closure of international borders bought this channel to a halt that accounted for 60-70% of the region's revenue.
After an escalation in the political tensions between China and Australia, A2 Milk in May slashed its sales and earnings forecasts again and wrote down $90 million in nearly out-of-date stock, sending the share price to a low of $5.02c, almost 75% below its 2020 high.
Last week, the beaten-down share price rallied briefly above $7.00 on reports that A2 Milk has become a takeover target for Nestle. A takeover by the Swiss giant would reinvigorate A2 Milk's infant formula in China and leverage Nestles in-country distribution network. A2 Milk has declined to comment on the takeover speculation leaving the market to ponder the possibilities of a takeover.
In its last update in May, A2 Milk said that it expects full-year sales to be in the range of $NZ1.2 billion to $NZ1.25 billion and an EBITDA margin of 11 percent to 12 percent. The latter implies an EBITDA of just NZ$132 million to NZ$150 million. This compares to FY 2020's revenue of NZ$1.73 billion and EBITDA of NZ$549.7 million, a reduction of 73% to 76% year on year.
After falling from $20.05 to a low of $5.02 in just 12 months, some stability has returned to the A2 Milk price recently. Nonetheless, there aren't any obvious technical or fundamental reasons to buy A2 Milk other than for the reason a corrective bounce is possible after such a sharp sell-off. For those that think that last week's takeover rumour might, in time, prove correct, then consider buying A2 Milk at $6.57 with a stop loss placed below $5.75.
Source Tradingview. The figures stated areas of the 23rd of August 2021. Past performance is not a reliable indicator of future performance. This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation
Latest market news
View more newsThe complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

S&P 500, Nasdaq, Dow Forecast: Rising Yields Test Rally Ahead of Nvidia, Fed 8 22 2026
S&P 500, Nasdaq and Dow test key technical levels as momentum fades, raising the risk of a deeper correction heading into a pivotal week.

ASX 200 Futures Reversal Patterns Put to the Test
Not all reversal patterns are created equal. Historical ASX 200 futures data shows which signals have been more reliable, and why risk management still matters.

Cyclical stocks sniff out better times ahead
Different economies, different drivers, similar price action. The German DAX, ASX 200 and Russell 2000 are all hinting at a more optimistic view on the global economy.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.






